首页 › 免疫系统与疾病 › 伊利诺伊州 › Chicago
Chicago IL 免疫系统与疾病临床试验
8项针对 免疫系统与疾病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
招募中观察性研究
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- Northwestern University, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Northwestern Memorial Hospital, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
招募中1/2 期
- University of Illinois Hospital & Health Sciences System, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- University of Chicago Medical Center, Chicago
Study of Gastric Motility in Eosinophilic Gastritis
招募中观察性研究
- Northwestern University, Chicago
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
招募中2 期
- University of Illinois Medical Center - Hematology & Oncology, Chicago
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
招募中4 期
- University of Chicago, Chicago
其他城市的 免疫系统与疾病试验
- Washington, DC13 项研究
- New York City, NY12 项研究
- Boston, MA10 项研究
- Portland, OR10 项研究
- Atlanta, GA10 项研究
- Philadelphia, PA10 项研究
- Houston, TX9 项研究
- Los Angeles, CA9 项研究
- Cleveland, OH8 项研究
- Seattle, WA6 项研究
- Milwaukee, WI6 项研究
- Tampa, FL6 项研究
Chicago的其他研究
- 乳腺癌59 项研究
- 非小细胞肺癌59 项研究
- 癌症（所有类型）51 项研究
- 前列腺癌45 项研究
- 肺癌43 项研究
- 转移性癌症42 项研究
- 肥胖症40 项研究
- 卵巢癌36 项研究
- 结直肠癌32 项研究
- 卒中31 项研究
- 头颈鳞状细胞癌29 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。